We know that living with prostate cancer affects not just you but also your spouse and your entire family. A solid source of support can make a tremendous difference when you or someone you love is going through or recovering from cancer treatment. Join us on the first Tuesday of each month at the OHSU Center for Health & Healing to share experiences and resources with others on a similar journey.
Prostate Cancer Support Group
Our prostate cancer support group meets monthly and is very active in the community through our prostate cancer advocacy group. We are here to give you the information and emotional support you need. We can also help you create a support plan that meets your needs. We provide counseling and emotional support for prostate cancer patients and their families.
Meetings are held the first Tuesday of each month from 5 - 6:30 p.m. at:
OHSU Center for Health & Healing
3303 S.W. Bond Avenue
3rd Floor Conference Center, Room 1A & 1B
Portland, OR 97239
Each meeting begins with brief introductions and announcements. Then an expert speaks for about 45 minutes on a relevant topic, saving time for questions. The last 30 minutes are reserved for informal check-in and discussion. Following the meeting, you are welcome to use the comfortable furniture and visit informally in the first-floor lobby.
For more information please contact Peter Bennett at 503 418-3544 or at email@example.com
Genomics, technology and research on the latest treatments for prostate cancer
Tuesday, February 7, 5 p.m.
Bryce Olson, Intel employee, prostate cancer survivor
Bryce is an expert in bringing technology and science together in the exciting area of genomics and personalized medicine, with a powerful message on how this saves lives. As an advanced prostate cancer patient, he is experiencing firsthand the importance of being an active, informed patient. Armed with genomic sequencing data pinpointing the mutations that drove his cancer, Bryce's oncologist, Tom Beer, M.D., helped him find a clinical trial that offered the potential to shut those mutations down. The trial has been a success for over 19 months (as of November 2016) and Bryce has become a fierce advocate for patients to get access to tests that open the door to more targeted therapeutics. Bryce will share his story and discuss the current challenges and opportunities patients face in dealing with providers, pharmaceutical companies and clinical trials, payers, and policy related to genomic sequencing and precision medicine. Knowledge gained during this session will be particularly useful in preparation for the March session on immunotherapy with Julie Graff, M.D.
Introduction to clinical trials and a new research on immunotherapy for prostate cancer
Tuesday, March 7, 5 p.m.
Julie Graff, M.D., medical oncologist at OHSU and VA Medical Center
Rachel Slottke, clinical research coordinator team lead for prostate cancer research, OHSU Knight Cancer Institute
Rachel will provide an overview of clinical research trials for prostate cancer, and Dr. Graff will share some of her findings related to a study combining pembrolizumab and enzalutamide.
Immunotherapy is a rapidly growing treatment for cancer. It has been shown to work in melanoma, lung cancer, kidney cancer and bladder cancer. However, results in prostate cancer have been disappointing. The OHSU Knight Cancer Institute is leading the way in combination therapy with an immune checkpoint inhibitor (pembrolizumab) and an androgen receptor antagonist (enzalutamide). So far the cancer in five patients has responded exceptionally and we are working to know more about why. Dr. Graff will present the results so far and future research to be performed.
Tuesday, April 4, 5 p.m.
Open discussion with breakout session for spouses and significant others.
Prostate cancer survivorship: an important measure of the total patient experience
Tuesday, May 2, 5 p.m.
Amy Leatherwood, R.N., M.S.N., F.N.P.-B.C., Radiation Medicine, OHSU Knight Cancer Institute
Hilary Shreves, M.S.N., A.C.N.P.-B.C., Urology, OHSU Knight Cancer Institute
Hillary and Amy specialize in life after cancer; they lead two different programs at OHSU for survivors. In this session, they bring their extensive experience to share how ongoing monitoring, symptom management and communication can help you attain the highest quality of life post prostate cancer treatment. Further, they can help you identify the impact cancer treatment has on all aspects of your life and bring health and healing. Lastly, they will cover the status and future of what it means to be a cancer survivor in this nation.
As lead survivorship nurse practitioner, Amy has spent the past four years in program development, clinical work, cross-disciplinary collaboration, and research studies involving cancer survivors. A large portion of her survivorship patients are prostate cancer survivors.
As director of the urologic survivorship program, Hilary cares for patients with a variety of urologic cancers, including many with prostate cancer.
Caregiving and relating to the prostate cancer experience
Tuesday, June 6, 5 p.m.
Katie Hennessy, L.C.S.W., OHSU Knight Cancer Institute
In this session, especially designed for friends and family, Katie will share how to best care for and understand someone during their journey through prostate cancer.
Katie brings 12 years of experience supporting patients and families affected by cancer as both co-founder of this support group and seeing outpatient palliative care patients in the OHSU Hematology and Medical Oncology clinic.
Our prostate cancer advocacy group meets as needed.
This patient group works to increase prostate cancer research and treatment awareness across Oregon.
To get involved call 503 494-4393
Our friend-to-friend telephone program helps connect prostate cancer patients who may have had similar experiences with patients who volunteer their time to listen and support you. To be connected with a volunteer call 503 494-4393
Check the OHSU Knight Cancer Institute calendar for more upcoming meetings.